Torrent Pharmaceuticals Ltd Share Price – NSE /  BSE

Pharmaceuticals, Mid Cap

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Torrent Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting at Rs 4369, up 0.14% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 24164.3. The Sensex is at 77254.26, down 0.76%. Torrent Pharmaceuticals Ltd has added around 6.7% in last one month.

Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has added around 9.02% in last one month and is currently quoting at 24135.5, down 0.02% on the day. The volume in the stock stood at 67292 shares today, compared to the daily average of 3.37 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 4385.1, up 0.22% on the day. Torrent Pharmaceuticals Ltd is up 39.09% in last one year as compared to a 0.65% gain in NIFTY and a 14.52% gain in the Nifty Pharma index.

The PE of the stock is 66.05 based on TTM earnings ending December 25.

Powered by Capital Market - Live News

Torrent Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 4341.6, up 1.56% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 24018.3. The Sensex is at 76839.15, down 0.23%. Torrent Pharmaceuticals Ltd has gained around 7.17% in last one month.

Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has gained around 10.1% in last one month and is currently quoting at 23568.95, up 2.16% on the day. The volume in the stock stood at 1.32 lakh shares today, compared to the daily average of 3.58 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 4375, up 1.94% on the day. Torrent Pharmaceuticals Ltd is up 31.92% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the Nifty Pharma index.

The PE of the stock is 64.8 based on TTM earnings ending December 25.

Powered by Capital Market - Live News

The inspection was conducted between 6 April and 10 April 2026.

A zero-observation outcome indicates that no Form 483 was issued by the regulator, reflecting compliance with current good manufacturing practices (cGMP) at the facility.

The development is positive for the company?s oncology portfolio and supports its regulatory standing in the US market.

Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.

The company?s consolidated net profit jumped 27.6% to Rs 642 crore on 17.7% rise in revenue from operations to Rs 3,251 crore in Q3 FY26 over Q3 FY25

Shares of Torrent Pharmaceuticals rose 0.60% to Rs 4,180 on the BSE.